As of: March 18, 2024, 3:09 p.m
By: Nadja Pohr
Comments
Press
Split
CureVac has announced job cuts that will affect some employees in Baden-Württemberg.
© dpa/Bernd Weißbrod
Vaccine manufacturer CureVac is still developing a new corona vaccine.
At the same time, the company from Baden-Württemberg announced job cuts.
Tübingen - CureVac, the biotech company from Baden-Württemberg, is known for its research on its own corona vaccine.
A recent decision by the company could hit some employees hard.
BW24
reports on the vaccine manufacturer's job cuts and who will be affected.
Despite setbacks in the past, the company has not given up on research.
Together with the British partner GlaxoSmithKline (GSK), CureVac is working on a new second-generation corona vaccine.
But that's not all: the company also wants to break new ground in cancer therapy.
The editor Nadja Pohr wrote this article and then used an AI language model for optimization at her own discretion. All information has been carefully checked.